You are here: Industry Insights > Novotech

News List

Novotech Acquires US-based Drug Development Consulting Firm, CBR International PharmaSources
January 12, 2023
Expands Drug Development and FDA Regulatory Expertise
Novotech Acquires European CRO, Strengthens Global Operations PharmaSources
January 12, 2023
The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has over 250 employees.
Novotech Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials prnasia
July 20, 2021
Novotech Health Holdings Pte. Ltd. joins a historic alliance of over one hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
Novotech highlights South Korea's plans on clinical trials advancements biospectrumasia
September 16, 2019
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety servi
Novotech, CNS to expand CRO services to biopharma across APAC biospectrumasia
November 23, 2018
As part of the deal, clients can access leading services from both groups including the CNS BioDesk, that provides early stage product development advice including toxicology,
Novotech wins 2017 Asia Pacific Biotech CRO award prnasia
January 09, 2018
Leading Asia Pacific CRO Novotech has won Asia Pacific Biotech CRO Company of The Year award in Frost & Sullivan's 2017 Best Practice Awards.
Novotech signs MOU with South Korea's SCI-Consortium and Severance Hospital biospectrumasia
August 01, 2017
The network provides clinical trial access to over 1,500 investigators, almost 6,000 hospital beds and more than seven million patients per year.
Novotech and Sonic Clinical Trials signs central lab services agreement biospectrumasia
June 28, 2017
This partnership will enable Novotech clients to select from a wide menu of assays or biomarkers, access a trial-specific kit assembly service and use a single clinical trial-dedicated laboratory